VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
08 01 2020
Historique:
accepted: 29 09 2019
revised: 17 09 2019
received: 22 08 2019
pubmed: 8 10 2019
medline: 19 5 2020
entrez: 8 10 2019
Statut: ppublish

Résumé

Here, we report an update of the VDJdb database with a substantial increase in the number of T-cell receptor (TCR) sequences and their cognate antigens. The update further provides a new database infrastructure featuring two additional analysis modes that facilitate database querying and real-world data analysis. The increased yield of TCR specificity identification methods and the overall increase in the number of studies in the field has allowed us to expand the database more than 5-fold. Furthermore, several new analysis methods are included. For example, batch annotation of TCR repertoire sequencing samples allows for annotating large datasets on-line. Using recently developed bioinformatic methods for TCR motif mining, we have built a reduced set of high-quality TCR motifs that can be used for both training TCR specificity predictors and matching against TCRs of interest. These additions enhance the versatility of the VDJdb in the task of exploring T-cell antigen specificities. The database is available at https://vdjdb.cdr3.net.

Identifiants

pubmed: 31588507
pii: 5582255
doi: 10.1093/nar/gkz874
pmc: PMC6943061
doi:

Substances chimiques

Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

D1057-D1062

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Annu Rev Immunol. 2019 Apr 26;37:547-570
pubmed: 30699000
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9604-9609
pubmed: 30158170
PLoS Biol. 2019 Jun 13;17(6):e3000314
pubmed: 31194732
Elife. 2018 Aug 28;7:
pubmed: 30152754
Nucleic Acids Res. 2018 Jan 4;46(D1):D419-D427
pubmed: 28977646
J Autoimmun. 2018 Dec;95:100-123
pubmed: 30509385
Trends Cancer. 2019 Feb;5(2):85-94
pubmed: 30755308
Bioinformatics. 2017 Sep 15;33(18):2924-2929
pubmed: 28481982
Front Immunol. 2019 Sep 26;10:2159
pubmed: 31616409
Nat Biotechnol. 2016 Oct;34(10):1037-1045
pubmed: 27571370
Front Immunol. 2018 Nov 20;9:2688
pubmed: 30515166
BMC Genomics. 2016 Jun 13;17:453
pubmed: 27297497
Nat Immunol. 2017 Nov 16;18(12):1274-1278
pubmed: 29144493
Nat Genet. 2017 May;49(5):659-665
pubmed: 28369038
Bioinformatics. 2019 May 1;35(9):1461-1468
pubmed: 30247624

Auteurs

Dmitry V Bagaev (DV)

Pirogov Russian Medical State University, Moscow, Russia.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Renske M A Vroomans (RMA)

Origins Center, Groningen, The Netherlands.
Institute for Advanced Study, University of Amsterdam, Amsterdam, The Netherlands.

Jerome Samir (J)

Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, Australia.
School of Medical Sciences, UNSW Sydney, Sydney, Australia.

Ulrik Stervbo (U)

Center for Translational Medicine, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.

Cristina Rius (C)

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.

Garry Dolton (G)

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.

Alexander Greenshields-Watson (A)

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.

Meriem Attaf (M)

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.

Evgeny S Egorov (ES)

Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Ivan V Zvyagin (IV)

Pirogov Russian Medical State University, Moscow, Russia.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Nina Babel (N)

Center for Translational Medicine, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.

David K Cole (DK)

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
Immunocore Ltd., Abingdon, OX14 4RY, UK.

Andrew J Godkin (AJ)

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.

Andrew K Sewell (AK)

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.

Can Kesmir (C)

Theoretical Biology and Bioinformatics Department, Science Faculty, Utrecht University, Utrecht, Netherlands.

Dmitriy M Chudakov (DM)

Pirogov Russian Medical State University, Moscow, Russia.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.

Fabio Luciani (F)

Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, Australia.
School of Medical Sciences, UNSW Sydney, Sydney, Australia.

Mikhail Shugay (M)

Pirogov Russian Medical State University, Moscow, Russia.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH